CTOs on the Move


 
As a nonprofit engineering innovation company, Draper serves our nation`s interests and security needs; advances technologies at the intersection of government, academia, and industry; cultivates the next generation of innovators; and solves the most complex challenges. Multidisciplinary teams drawn from a broad and deep talent pool of 1,200 engineers and scientists collaborate to develop first-of-a-kind solutions. Our unbiased approach enables us to focus on our customers` needs and to deliver new capabilities to them.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.draper.com
  • 555 Technology Square
    Cambridge, MA USA 02139
  • Phone: 617.258.1000

Executives

Name Title Contact Details
Jennifer Doherty
Vice President, Chief Security Officer and Chief Information Officer Profile
Jonathan Cos
Associate Director of Information Security Profile
Kevin Burns
Chief Information Security Officer Profile

Similar Companies

Christian Counseling Center

Christian Counseling Center is a Orland Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ArcherDX

ArcherDX, Inc., creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built to identify mutations and gene fusions from clinical sample types.

Kali-Extracts

Making lives better with natural botanical therapies derived from our patented extraction process

Neoleukin

Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.

Escient Pharmaceuticals

Based in San Diego, we are led by an experienced team of entrepreneurs with deep roots in this region`s life sciences ecosystem and specific expertise in GPCR drug discovery and development. Escient Pharmaceuticals is supported by top-tier life-sciences investors with a proven track record for identifying and supporting successful, next-generation medicines companies.